NR4A1 and cancer: The following data are organized into an overall assessment of HRT (recurrence and mortality), followed by a synthesis of the impact of (1) oral vs. vaginal HRT; (2) hormone receptor–positive vs. hormone receptor–negative cancer; and (3) treatment duration.